Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02285972
Other study ID # Odu-5
Secondary ID
Status Completed
Phase Phase 4
First received November 1, 2014
Last updated April 18, 2015
Start date November 2014
Est. completion date April 2015

Study information

Verified date November 2014
Source T.C. ORDU ÜNIVERSITESI
Contact n/a
Is FDA regulated No
Health authority Turkey: Ministry of Health
Study type Interventional

Clinical Trial Summary

Propofol remains the most common drug for induction of general anaesthesia, although it causes considerable pain or discomfort on injection. Anesthesia providers have attempted a large number of remedies to prevent this pain on injection. Previously explored ideas include injecting propofol into larger veins, warming of the hand with hot packs, and intravenous pretreatment with numerous other medications. No studies to date have looked at the dexketoprofen and tenoxicam for the pretreatment of pain on injection caused by propofol. The investigators propose studying the use of dexketoprofen and tenoxicam for pretreatment of propofol related pain on injection.


Recruitment information / eligibility

Status Completed
Enrollment 118
Est. completion date April 2015
Est. primary completion date April 2015
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria:

- American Society of Anesthesiologists (ASA) physical status 1 and 2

- 18 - 65 years

- general anesthesia scheduled for elective surgery

Exclusion Criteria:

- age < 18 years, > 65 years

- pregnancy

- patients requiring a rapid sequence induction

- refusal to participate and patients already participating in another study

- allergy to study drugs

- communication difficulty

- psychiatric and neurolojic disorders

- use of analgesics or sedative drugs within 24 hours before surgery.

- emergency surgery

- history of drug or alcohol abuse

- ASA 3 and above

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Prevention


Related Conditions & MeSH terms


Intervention

Drug:
saline
before the anesthesia induction, 2mL saline iv injection
dexketoprofen
before the anesthesia induction, 50 mg (2mL) iv dexketoprofen
tenoxicam
before the anesthesia induction, 20 mg (2mL) iv tenoxicam

Locations

Country Name City State
Turkey Anesthesiology and Reanimation Dept. Ordu University Training and Research Hospital Altinordu Ordu

Sponsors (1)

Lead Sponsor Collaborator
T.C. ORDU ÜNIVERSITESI

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary Verbal Pain Score Approximately one minute following administration of propofol. No
Primary Facial Pain Score Approximately one minute following administration of propofol. No
See also
  Status Clinical Trial Phase
Completed NCT04008433 - Median Effective Dose of Lidocaine for the Prevention of Pain Caused by the Injection of Propofol Formulated With Medium-/Long-chain Triglycerides N/A
Completed NCT04943367 - Effect of TEAS on Rocuronium Injection Pain N/A
Recruiting NCT05217238 - Median Effective Dose of Remifentanil for the Prevention of Pain Caused by the Injection of Rocuronium N/A
Completed NCT03772483 - Efficacy of Virtual Reality in Reducing Injection Pain and Anxiety During Local Anesthesia in Children N/A